Ronald e. Osman

US·SEC (Form 4)

Inhibitor Therapeutics, Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 04 Aug 2026 for Inhibitor Therapeutics, Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Ronald e. Osman: trading record in brief

Ronald e. Osman is a declared insider of Inhibitor Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 11 August 2023 to 4 May 2026, the count stands at 4 filings.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 4 August 2026 came the latest disclosure, a share grant in Inhibitor Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 32 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.